Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 1,1811,200 of 20,252 grants

Active NON-SBIR/STTR RPGS
Effects of the oral environment on KSHV shedding in Ugandan adults living with HIV
NATIONAL CANCER INSTITUTE University of Colorado Denver United States 2024 – 2029

Project Summary/Abstract In sub-Saharan Africa (SSA), Kaposi’s sarcoma-associated herpesvirus (KSHV), the etiological agent of Kaposi’s sarcoma (KS), is endemic and HIV incidence i...

$5.46M
USD
Active NON-SBIR/STTR RPGS
Identifying modifiable multi-level factors associated with HPV vaccine uptake in Kenya and Malawi
NATIONAL CANCER INSTITUTE New York University United States 2024 – 2029

Project Summary/Abstract Cervical cancer burden falls disproportionately on women in low- and middle-income countries. Achieving cervical cancer elimination in these high-burden se...

$6.44M
USD
Active NON-SBIR/STTR RPGS
Randomized controlled trial of varenicline to treat tobacco and cannabis co-use.
NATIONAL CANCER INSTITUTE Medical University of South Carolina United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT The co-use of tobacco and cannabis is prevalent, appears to be increasing among adults in the United States (US), and has been shown to adversely affect tr...

$6.03M
USD
Active NON-SBIR/STTR RPGS
Bhlhe40 Regulation of T Cell Function During Cancer Immunotherapy
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT For cancer immunotherapies such as immune checkpoint therapy (ICT), success depends on sustained activation of intratumoral effector T cells recognizing tu...

$6.07M
USD
Active NON-SBIR/STTR RPGS
Preventing Fatal Infections in Children with Down Syndrome During Treatment for Acute Lymphoblastic Leukemia
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2024 – 2029

SUMMARY Children with Down syndrome (DS) have a 20-fold increased risk of developing acute lymphoblastic leukemia (ALL), a rate that is significantly higher than the general popula...

$5.48M
USD
Completed OTHERS
Next Generation T cell therapies for childhood cancers (NexTGen)
NATIONAL CANCER INSTITUTE New York University School of Medicine United States 2024 – 2025

Next Generation T cell therapies for childhood cancers [NexTGen] Current treatments fail to cure many children with solid cancers.Recent advances in adult cancers such as checkpoin...

$764.9K
USD
Completed OTHERS
eDyNAmiC (extrachromosomal DNA in Cancer) - Understanding the biology of ecDNA generation and action, and developing new ways to target these mechanisms in cancer
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2024 – 2025

Abstract: eDyNAmiC (extrachromosomal DNA in Cancer) Human genes are arranged on 23 pairs of chromosomes, but in cancer, tumour-promoting genes can free themselves from chromosomes...

$1.66M
USD
Active RESEARCH CENTERS
Project 4 LUNG
NATIONAL CANCER INSTITUTE University of Florida United States 2024 – 2026

ABSTRACT – FULL PROJECT 4 LUNG Lung cancer is a prominent source of cancer health disparity, particularly in Black men. While they have lower exposure to cigarette smoke, the most...

Active NON-SBIR/STTR RPGS
Protein kinase C and lung carcinogenesis
NATIONAL CANCER INSTITUTE University of Miami School of Medicine United States 2024 – 2028

ABSTRACT Lung cancer is the leading cause of cancer-related deaths in the U.S., with ~236,700 new cases and ~130,200 deaths estimated for 2022. A joint effort by both PIs in this g...

$6.41M
USD
Completed SBIR-STTR RPGS
A novel targeted antibody therapeutic to treat ovarian cancer
NATIONAL CANCER INSTITUTE Trio Pharmaceuticals Inc United States 2024 – 2025

PROJECT SUMMARY Ovarian Cancer (OvCa) is the fifth leading cause of cancer deaths for women and is associated with very low survivability. Current treatment strategies for OvCa lar...

$3.99M
USD
Completed SBIR-STTR RPGS
DEVELOPMENT OF A WEARABLE, NON-INVASIVE, TREATMENT DEVICE FOR METASTATIC TRIPLE-NEGATIVE BREAST CANCER (TNBC)
NATIONAL CANCER INSTITUTE Embiosys Inc United States 2024 – 2026

PROJECT SUMMARY/ABSTRACT Triple-negative breast cancer (TNBC) is a subtype of breast cancer that is highly invasive, has limited treatment options, and is prone to recurrence and m...

$2.11M
USD
Completed TRAINING, INDIVIDUAL
Metabolic reprogramming in Fanconi anemia-deficient head and neck squamous cell carcinoma
NATIONAL CANCER INSTITUTE University of Cincinnati United States 2024 – 2025

Project Summary/Abstract I am an MD/PhD student in the laboratory of Dr. Susanne Wells at Cincinnati Children’s Hospital Medical Center and the University of Cincinnati College of...

$463.9K
USD
Active NON-SBIR/STTR RPGS
Harnessing low-field MRI and robotics to enable personalized incisionless prostate surgery
NATIONAL CANCER INSTITUTE Case Western Reserve University United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT Objective: The overarching goal of our research is to replace invasive radical prostatectomy with targeted, mini- mally invasive image-guided focal resecti...

$6.07M
USD
Active TRAINING, INDIVIDUAL
Engineering RIG-I Activating Nanoparticles for Glioblastoma Immunotherapy
NATIONAL CANCER INSTITUTE Vanderbilt University United States 2024 – 2027

Glioblastoma (GBM) is a form of brain cancer with no cure and a five-year survival rate below 10%. Immunotherapies such as immune checkpoint blockade (ICB) have shown great promise...

$738.3K
USD
Completed OTHER RESEARCH-RELATED
Addressing the Training Gap in Oncology on Sexual Health: Development of the Sexual Health Integrative Fellowship Training (SHIFT) Course for Hematology-Oncology Fellows
NATIONAL CANCER INSTITUTE Research Inst of Fox Chase Can Ctr United States 2024 – 2026

PROJECT SUMMARY Over half of patients treated for cancer report concerns related to sexual health. If unaddressed, such concerns can cause substantial distress and compromise patie...

$1.62M
USD
Completed OTHER RESEARCH-RELATED
Quantitatively predicting drug-resistant mutations to improve precision oncology
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2024 – 2026

PROJECT SUMMARY Quantitatively predicting drug-resistant mutations to improve precision oncology My work builds towards a mechanistically informed approach to model and predict dru...

$1.44M
USD
Active NON-SBIR/STTR RPGS
Deciphering functions of the ATR-METTL3-BRCA1 Axis in genome instability and Tumorigenesis
NATIONAL CANCER INSTITUTE Lundquist Institute for Biomedical Innov... United States 2024 – 2029

PROJECT SUMMARY /ABSTRACT A defect in DNA damage repair triggers genome instability as a hallmark of cancer that is exploited by treatments such as ionizing radiation, platinum che...

$4.6M
USD
Active NON-SBIR/STTR RPGS
HEME-Hospice: An Intervention to improve Hospice Use for Patients with Hematologic Malignancies
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2024 – 2029

PROJECT SUMMARY Hospice is the gold standard of quality end-of-life (EOL) care. As compared to the de-facto option of dying in a hospital, hospice improves quality of life (QOL), r...

$7.32M
USD
Active NON-SBIR/STTR RPGS
Radiomic spatial maps for identifying viable tumor extent on multi-parametric MRI for Glioblastoma
NATIONAL CANCER INSTITUTE University of Wisconsin-Madison United States 2024 – 2029

ABSTRACT: Glioblastoma (GBM) has a complex infiltrating tumor microenvironment which extends well beyond the visible enhancing tumor margins and plays a substantial role in GBM rec...

$6.4M
USD
Completed SBIR-STTR RPGS
Clinical testing of Listeria-TT and Gemcitabine in a Phase I clinical trial with PDAC patients
NATIONAL CANCER INSTITUTE Loki Therapeutics, Inc United States 2024 – 2025

ABSTRACT The overall objective of this STTR Fast-Track project is to prepare and perform a Phase I clinical trial in metastatic unresectable pancreatic ductal cancer adenocarcinoma...

$2.95M
USD